clinical-collaboration-with-Amgen
Collaboration to study Boehringer Ingelheim’s SOS1::pan-KRAS Inhibitor in combination with Amgen’s KRASG12C Inhibitor
Search
Generalized pustular psoriasis: Value of community support
Dr Clerisme-Beaty and Dr Strober MD, PhD discuss the importance of knowledge sharing, community support and challenges faced by those living with GPP.
How Boehringer Ingelheim has responded to the pandemic
As part of the pharmaceutical industry, Boehringer Ingelheim joined the collective efforts in fighting COVID-19 ever since the start of the pandemic.
Our Biotech Story | Bioxcellence | Boehringer Ingelheim
Discover our pioneering history & leadership in biotechnology, driving innovation in biopharmaceutical manufacturing & breakthrough therapies.
Immunomodulator
Immunomodulator
STING agonist (2nd generation)
Second generation STING agonist
Partnership for new liver disease treatments with Ribo
Boehringer Ingelheim partners with Ribo to develop new treatments for people with liver diseases
Ion channel inhibitor
Ion channel inhibitor
“Rapid progress towards clinical candidates”
Boehringer Ingelheim forms a joint venture to create the next generation of antimicrobials.
Phospholipid modulator
Phospholipid modulator
Lysophospholipase inhibitor
Lysophospholipase inhibitor
Vascular modulator
Vascular modulator
Generalized pustular psoriasis: Unmet needs
Dr Clerisme-Beaty and Dr Strober MD, PhD discuss the impact of living with GPP including unseen challenges and future management.
NDMA regulator
NDMA regulator
Anti-fibrotic agent
Anti-fibrotic agent
VSV-GP
VSV-GP
C3-binding polypeptide
C3-binding polypeptide
Modified yersinia
Modified yersinia
DLL3/CD3 T-cell engager
DLL3/CD3 T-cell engager
GLP-1/FGF21 agonist
GLP-1/FGF21 agonist
Nerandomilast (BI 1015550)
Nerandomilast (BI 1015550): PDE4B inhibitor
biopharmaceuticals-in-china
Boehringer Ingelheim manufactures the first biopharmaceutical approved in China under new MAH contract manufacturing regulatory system.
CD137/FAP agonist
CD137/FAP agonist
Brigimadlin
MDM2-p53 antagonist
B7-H6/CD3 T-Cell Engager
B7-H6/CD3 T-Cell Engager